Product Information
CIPROFLOXACIN HCL 750 MG TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2655 per EA under NDC 16571041305. Its NADAC has been published 645 times since Nov 28, 2013.
Strength
750 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571041305
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CIPROFLOXACIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076639On Market Since
9/10/2004
Pharmacological Classes
Price Statistics
The NADAC for CIPROFLOXACIN HCL 750 MG TAB has been published 645 times since Nov 28, 2013, and over the history we have for it it has risen 6.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2655 per EA |
|---|---|
| All-time high | $0.3928 (Feb 10, 2016) |
| All-time low | $0.1714 (Nov 21, 2018) |
| 52-week high | $0.2655 |
| 52-week low | $0.2433 |
| Median price | $0.2632 |
| Average price | $0.2689 |
| Largest weekly change | +60.8% (Feb 23, 2022) |
| Weeks tracked | 645 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ciprofloxacin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CIPROFLOXACIN HCL 750 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CIPROFLOXACIN HCL 750 MG TAB, manufactured by Rising Pharma Holdings Inc., is $0.2655 per EA (NDC 16571041305), effective Jun 24, 2026.
How has the price of CIPROFLOXACIN HCL 750 MG TAB changed over time?
Over the history we have for it, the NADAC for CIPROFLOXACIN HCL 750 MG TAB has risen 6.9%. It has been tracked across 645 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CIPROFLOXACIN HCL 750 MG TAB?
Since Nov 28, 2013, the NADAC for CIPROFLOXACIN HCL 750 MG TAB has ranged from a low of $0.1714 (Nov 21, 2018) to a high of $0.3928 (Feb 10, 2016), with a median of $0.2632 per EA.
Are there cheaper alternatives to CIPROFLOXACIN HCL 750 MG TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CIPROFLOXACIN HCL 750 MG TAB, so no direct lower-cost alternative is listed.
Who manufactures CIPROFLOXACIN HCL 750 MG TAB?
CIPROFLOXACIN HCL 750 MG TAB (NDC 16571041305) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification